Curis Receives Nasdaq Delisting Notice Due to Minimum Bid Price Deficiency

On April 27, 2026, Curis, Inc. received a Delist Determination Letter from the Nasdaq Stock Market's Listing Qualifications Department. The notice was issued because the bid price for the company’s common stock had closed below the minimum $1.00 per share requirement for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). Curis was already under a one-year Discretionary Panel Monitor as of February 3, 2026, which stripped the company of standard cure periods for new deficiencies. Consequently, Nasdaq scheduled the company’s securities for delisting and suspension at the opening of trading on May 6, 2026. Curis intends to appeal this determination by requesting a hearing before the Nasdaq Hearings Panel by the May 4, 2026 deadline. A timely request for a hearing will stay the delisting process pending the Panel’s decision. However, there is no guarantee that the appeal will be successful or that the company will maintain its listing on the Nasdaq Capital Market.